Literature DB >> 11739122

Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule.

Bruno A Escalante1, John C McGiff, Adebayo O Oyekan.   

Abstract

We examined the rat proximal tubule (PT) response to endothelin-1 (ET-1) in terms of 20-hydroxyeicosatetraenoic acid (HETE) dependency. Arachidonic acid (AA) (1 microM) decreased ouabain-sensitive (86)Rb uptake from 2.1 +/- 0.1 to 0.3 +/- 0.08 ng Rb. 10 microg protein(-1). 2 min(-1) (P < 0.05); 20-HETE (1 microM) had similar effects. Dibromododecenoic acid (DBDD) (2 microM), an inhibitor of omega-hydroxylase, abolished the inhibitory action of AA on (86)Rb uptake whereas the PT response to 20-HETE was unaffected. ET-1 at 0.1, 1, 10, and 100 nM reduced (86)Rb uptake from 2.8 +/- 0.3 in control PTs to 2.4 +/- 0.2, 1.7 +/- 0.1, 0.67 +/- 0.08, and 0.1 +/- 0.03 ng Rb. 10 microg protein(-1). 2 min(-1), respectively. DBDD (2 microM) abolished the inhibitory effect of ET-1 on (86)Rb uptake as did BMS182874 (1 microM), an ET(A)-selective receptor antagonist. ET-1 (100 nM) significantly increased PT 20-HETE release by approximately 50%, an effect prevented by DBDD. N(omega)-nitro-L-arginine-methyl ester (L-NAME), given for 4 days to inhibit nitric oxide synthase (NOS), increased arterial pressure from 92 +/- 12 to 140 +/- 8 mmHg and increased endogenous release of 20-HETE from isolated PTs (measured by gas chromatography/mass spectrometry). In L-NAME-treated PTs, but not in control PTs, 0.1 microM AA inhibited ouabain-sensitive (86)Rb uptake by > 40%; the response to AA was attenuated by DBDD. We conclude that, in the PTs, 1) 20-HETE is a second messenger for ET-1 and 2) conversion of AA to 20-HETE is augmented when NOS is inhibited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739122     DOI: 10.1152/ajprenal.0064.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  13 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

Review 4.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

5.  Regulation of the epithelial Na+ channel by endothelin-1 in rat collecting duct.

Authors:  Vladislav Bugaj; Oleh Pochynyuk; Elena Mironova; Alain Vandewalle; Jorge L Medina; James D Stockand
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

6.  Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.

Authors:  Dowhan Ahn; Yuqiang Ge; Peter K Stricklett; Pritmohinder Gill; Deborah Taylor; Alisa K Hughes; Masashi Yanagisawa; Lance Miller; Raoul D Nelson; Donald E Kohan
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat.

Authors:  Hantz C Hercule; Mong-Heng Wang; Adebayo O Oyekan
Journal:  J Physiol       Date:  2003-07-11       Impact factor: 5.182

8.  Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production.

Authors:  Bahar Tunctan; Fariborz A Yaghini; Anne Estes; Kafait U Malik
Journal:  Arch Pharm Res       Date:  2008-08-14       Impact factor: 4.946

9.  Bioactive lipid mediators in polycystic kidney disease.

Authors:  Jelena Klawitter; Jost Klawitter; Kim McFann; Alexander T Pennington; Kaleab Z Abebe; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Berenice Gitomer; Uwe Christians; Robert W Schrier
Journal:  J Lipid Res       Date:  2013-12-16       Impact factor: 5.922

10.  Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.

Authors:  Pietro Minuz; Houli Jiang; Cristiano Fava; Lucia Turolo; Stefania Tacconelli; Marco Ricci; Paola Patrignani; Alberto Morganti; Alessandro Lechi; John C McGiff
Journal:  Hypertension       Date:  2008-03-31       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.